No Approved Therapeutic Claims

Also known as: Mahalagang Paalala Warning · FDA Supplement Disclaimer · FDA Circular 2013-022 Disclaimer

Definition

“No Approved Therapeutic Claims” is a mandatory consumer health warning and labeling requirement enforced by the Food and Drug Administration (FDA) of the Philippines for all dietary supplements, herbal mixtures, and food products making health-related claims. The disclaimer must be prominently displayed on both the packaging labels and in all marketing, advertising, or promotional materials. Its primary purpose is to clearly inform the public that the product is registered as a food or supplement rather than a pharmaceutical drug, and that its health claims have not been scientifically validated or evaluated by the FDA for the treatment, prevention, or cure of any disease. To ensure maximum accessibility, advertisements in local media must also include the official Filipino translation: “Mahalagang Paalala: Ang [Pangalan ng Produkto] ay Hindi Gamot at Hindi Dapat Gamiting Panggamot sa Anumang Uri ng Sakit.” (FDA Philippines, DOH)

Identities

Source Type	Identity
Wikipedia	Dietary supplement regulation
Wikidata	N/A
DBpedia	N/A
ProductOntology	N/A
Wiktionary	disclaimer
Library of Congress Subject Headings (LCSH)	Dietary supplements — Law and legislation — Philippines
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	No Approved Therapeutic Claims FDA Philippines labeling
ConceptNet	disclaimer
OpenCyc	N/A

Also Known As

Mahalagang Paalala Warning
FDA Supplement Disclaimer
FDA Circular 2013-022 Disclaimer

Geography and Climate

As a national regulatory policy, the enforcement of the “No Approved Therapeutic Claims” disclaimer spans the entire geographical territory of the Philippines, including all 17 regions. The regulation applies equally to imported dietary supplements arriving through major international ports in Manila, Cebu, and Davao, as well as locally manufactured herbal products processed in regions characterized by diverse microclimates. The production of agricultural ingredients used in these supplements—such as mangosteen from Mindanao or lagundi from Luzon—is heavily influenced by the tropical climate, which dictates the seasonal availability and processing cycles of botanical ingredients before they are packaged and labeled under FDA supervision. (FDA Philippines)

Demographics

The demographic impact of this warning label reaches virtually the entire Philippine population, particularly targeting consumers who purchase over-the-counter health supplements. In terms of age demographics, usage of supplements is high among older adults seeking relief from chronic conditions, as well as health-conscious urban professionals. Socioeconomic demographics indicate that lower-income consumers often purchase herbal supplements as a cheaper alternative to prescription medicines, making the clear Filipino translation of the disclaimer critical for preventing dangerous self-medication practices among populations with limited access to formal healthcare.

Economy and Industry

The dietary supplement and herbal medicine industry in the Philippines is a multi-billion-peso market. The requirement to print the “No Approved Therapeutic Claims” warning directly impacts packaging design, advertising budgets, and compliance costs for hundreds of pharmaceutical and food manufacturing firms, including major domestic distributors like DMI Medical Supply Co. (distributor of MX3). Compliance with labeling laws is a prerequisite for obtaining a Certificate of Product Registration (CPR) from the FDA. Non-compliance, such as omitting the disclaimer or using unauthorized therapeutic claims in marketing campaigns, can result in severe financial penalties, product recalls, and the suspension of manufacturing licenses. (dti.gov.ph)

Transportation and Infrastructure

The distribution of labeled supplements relies on the country’s national logistics infrastructure, moving products from manufacturing plants and customs warehouses to pharmacies, supermarkets, and sari-sari stores nationwide. The FDA maintains regional administrative centers and laboratory facilities to test products for adulteration—such as the mixing of active pharmaceutical ingredients into food supplements. Regulatory compliance is verified at physical retail points and during transit by FDA inspectors, who ensure that all supplement shipments bear the approved labels before they enter regional distribution networks.

Culture and Tourism

The cultural relationship with herbal medicines in the Philippines is deeply rooted in traditional practices, where traditional healers (albularyos) historically prescribed native plants. The “No Approved Therapeutic Claims” regulation represents a modern administrative effort to bridge the gap between traditional belief systems and evidence-based medicine. In local media culture, the rapid, monotone recitation of the Filipino disclaimer at the end of radio and television commercials has become a widely recognized cultural meme, frequently parodied in pop culture while still serving its serious consumer education function. (discoverdavao.ph)

Government and Administration

The administrative authority for enforcing this disclaimer lies with the Food and Drug Administration (FDA) of the Philippines, under the Department of Health (DOH). Key regulations governing this requirement include Republic Act No. 9711 (The FDA Act of 2009) and DOH Administrative Order No. 2010-0008, which was later amended by FDA Circular No. 2013-022 to standardize the size, font (Arial, bold, capitalized), and placement of the warning. The FDA collaborates with the Department of Trade and Industry (DTI) and the Ad Standards Council (ASC) to monitor advertising copy and prosecute companies that engage in deceptive marketing practices. (FDA Philippines, dhsud.gov.ph)

Education and Healthcare

Healthcare professionals, including doctors, pharmacists, and nurses, play a critical role in educating patients about the meaning of the “No Approved Therapeutic Claims” label. Medical societies frequently run public health campaigns advising patients that dietary supplements should not replace prescribed medications for critical illnesses such as diabetes, hypertension, or cancer. The warning acts as a legal and educational barrier, forcing consumers to recognize the distinction between unregulated nutritional support and clinically proven pharmaceutical interventions.

Examples and Analogies

The Educational Safety Valve: The disclaimer acts like the warning label on a package of fireworks; it does not stop the consumer from using the product, but it clearly warns them that the product is not designed to be used safely inside a house (or in this case, to treat an actual disease without a doctor).
Food, Not Medicine: Just as a bottle of mineral water cannot claim to cure dehydration-related kidney damage, a dietary supplement bearing this disclaimer is legally categorized as a food item rather than a targeted therapeutic agent.

Usage Scenarios

1. Supplement Label Approval

A local manufacturer of mangosteen capsules submits their packaging layout to the FDA for review, ensuring that the phrase “NO APPROVED THERAPEUTIC CLAIMS” is printed in bold Arial, size 14, at the bottom of the principal display panel.

2. Advertising Copy Clearance

An advertising agency drafts a storyboard for a TV commercial for a herbal tea, making sure that the final frame displays the mandatory Filipino translation for at least four seconds with a voiceover reading the warning clearly.

Strategies

Implement strict quality control audits on marketing copy to ensure that promoters do not use words like “cure,” “heal,” or “prevent” in association with supplements.
Standardize the printing of the Filipino warning on all secondary packaging (cartons) to ensure that consumers read the disclaimer even if they discard the primary container.
Coordinate with the Ad Standards Council (ASC) to obtain clearance for all promotional materials before launching nationwide marketing campaigns.

Security and Safety Measures

Consumers should always consult a licensed physician before starting any dietary supplement, particularly if they are already taking prescription medications.
Do not purchase food supplements that lack the “No Approved Therapeutic Claims” disclaimer, as this is a primary indicator of unregistered or counterfeit products.
Report any establishment or online seller that claims their supplement can cure specific diseases to the FDA Action Center via their official portal.

Historical Context

For decades, the regulation of traditional herbs and dietary supplements in the Philippines was highly fragmented, leading to widespread consumer confusion and deceptive marketing by unscrupulous companies. In 2010, the Department of Health issued Administrative Order No. 2010-0008, which mandated the English disclaimer on all food supplements. However, because many consumers did not fully understand the term “therapeutic,” the regulation was widely criticized as ineffective. To address this, the FDA issued Circular No. 2013-022 under the leadership of Director General Kenneth Hartigan-Go, which introduced the mandatory Filipino translation: “Mahalagang Paalala: Ang [Pangalan ng Produkto] ay Hindi Gamot…” and specified exact layout dimensions. This regulatory shift helped protect consumers from substituting actual medical treatments with dietary supplements, establishing a clearer legal boundary for the natural health industry. (FDA Philippines)

Challenges and Controversies

The Translation and Comprehension Gap

Despite the mandatory Filipino translation, some consumer advocacy groups argue that many rural consumers still do not understand the regulatory distinction and continue to believe that highly advertised supplements possess curative properties.

Enforcement on Social Media

The rise of e-commerce platforms and social media marketing presents a massive enforcement challenge for the FDA, as individual resellers frequently post unauthorized health claims that bypass standard advertising review processes.